Johnson & Johnson: The Elephant in the Merck-Schering Living Room [View article]
This is a big issue that seems to garner little attention at the moment for JNJ. It is a heads i win, tails i don't lose anything scenario for JNJ. They have a pretty large free call option on the results of the arbitration with Schering-Plough/Merck.
Johnson & Johnson: The Elephant in the Merck-Schering Living Room [View article]